EIF2AK4 and lung disorder: Human patients with loss of function Gcn2 mutations have pulmonary disorders, including pulmonary veno-occlusive disease (PVOD), pulmonary arterial hypertension, and pulmonary capillary hemangiomatosis (18, 19, 20, 21).